Moreover, high neoantigen expression was associated with decreased mortality risk in the whole study samples, T-cell exhaustion subgroup, and PR positive subgroup, suggesting that neoantigens can serve as potential immunogenic agents to improve patient survival in breast cancer. Here, PGR is linked to breast cancer.